Aftermaster Inc. Notice to Shareholders
HOLLYWOOD, CA / ACCESSWIRE / September 21, 2021 / Aftermaster wants to notify its shareholders that it will not be able to complete its financial statements and be deemed current in its OTC Markets reporting obligations by September 28, 2021, and subsequently will be moved to the "expert market" on OTC Markets. Since exiting the chapter 11 subchapter 5 bankruptcy, the company has yet to secure the financing needed to move the company forward and get current. The company remains optimistic that it can secure the needed financing, but it does not know when or if it will be able to do so.
About Aftermaster Inc.
Aftermaster Audio Labs is an award-winning, leading edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. Aftermaster Audio Labs developed Aftermaster® audio, a true breakthrough in audio technology that brings extraordinary amplitude, depth, clarity and fullness to any audio recording throughout its entire frequency range, without compromise. The Aftermaster team's discography includes more hit records than any other audio technology company in the world. We know what sounds right.
Aftermaster products and divisions include: Aftermaster semiconductor chips and software for embedding in consumer products, Aftermaster developed and branded consumer and professional electronic products, Promaster on-line music mastering for independent music artists and in-studio professional music mastering services. For more information, please visit aftermaster.com/products
CONTACT:
Aftermaster Inc
Mirella Chavez
CFO
[email protected]
SOURCE: Aftermaster, Inc.
View source version on accesswire.com:
https://www.accesswire.com/664885/Aftermaster-Inc-Notice-to-Shareholders
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 31
- Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy
- Introducing Living Well: A Free, Evidence-Based Whole Health Column from Southern California University of Health Sciences
Create E-mail Alert Related Categories
ACCESS Newswire, Press ReleasesRelated Entities
BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share